Stockscreener 앱 받기
59.72
0.00%
0.00
시장 영업 전:
59.89
0.17
+0.28%
전일 마감가:
$59.72
열려 있는:
$59.195
하루 거래량:
6.82M
Relative Volume:
1.12
시가총액:
$23.42B
수익:
$4.30B
순이익/손실:
$571.50M
주가수익비율:
41.81
EPS:
1.4285
순현금흐름:
$570.80M
1주 성능:
+2.93%
1개월 성능:
-8.40%
6개월 성능:
-29.00%
1년 성능:
-17.66%
1일 변동 폭
$59.20
$60.85
1주일 범위
$54.11
$60.85
52주 변동 폭
$54.11
$93.25
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
DXCM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
59.72 | 23.25B | 4.30B | 571.50M | 570.80M | 1.4285 |
|
ABT
Abbott Laboratories
|
129.26 | 224.00B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
104.98 | 154.37B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
373.42 | 140.48B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.14 | 122.89B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
86.11 | 49.66B | 5.88B | 1.34B | 799.60M | 2.3489 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 개시 | Argus | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
Levi & Korsinsky Notifies DexCom, Inc. (DXCM) Shareholders of Class Action Lawsuit and December 26, 2025 Deadline - ACCESS Newswire
DexCom, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your Rights – DXCM - FinancialContent
ROSEN, A LEADING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important ... - Bluefield Daily Telegraph
ROSEN, A LEADING LAW FIRM, Encourages DexCom, Inc. - GlobeNewswire
Frank Sands Reduces Stake in DexCom Inc by 50.4%, Impacting Portfolio by -1.25% - Yahoo Finance
Legal and Regulatory Scrutiny Over Device Changes Might Change the Case for Investing in DexCom (DXCM) - Yahoo Finance
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Rothschild & Co Redburn Adjusts DexCom Price Target to $90 From $115, Maintains Buy Rating - MarketScreener
DexCom Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance
Allianz SE Has $4.54 Million Position in DexCom, Inc. $DXCM - Defense World
Will DexCom Inc. (DC4) stock keep high P E multiplesWeekly Earnings Recap & Low Drawdown Trading Techniques - newser.com
Winners And Losers Of Q3: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks - Yahoo Finance
DCXM ALERT: Kirby McInerney LLP Reminds DexCom, Inc. Investors of Important Deadline in Class Action Lawsuit - The AI Journal
DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class ActionContact Kessler Topaz Meltzer & Check, LLP - PR Newswire
Dexcom: director Heller sells $58,766 in shares By Investing.com - Investing.com UK
Statistical indicators supporting DexCom Inc.’s strengthJuly 2025 Catalysts & Smart Allocation Stock Reports - newser.com
DexCom Stock Just Fell to a 5-Year Low. Is It a No-Brainer Buy at This Price? - Nasdaq
Morgan Stanley Lowers DexCom (NASDAQ:DXCM) Price Target to $63.00 - Defense World
Has DexCom Inc. found a price floorWeekly Trading Summary & Free Expert Approved Momentum Trade Ideas - newser.com
DexCom Inc. stock outperforms competitors on strong trading day - MSN
DXCM Stockholders With Large Losses Should Contact Robbins LLP for Information About Leading the Dexcom, Inc. Securities Fraud Class Action - The Malaysian Reserve
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know - Yahoo Finance
DexCom Stock Surge: A Chance to Profit? - StocksToTrade
Decoding DexCom's Options Activity: What's the Big Picture? - Benzinga
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now - Yahoo Finance
Wall Street Pauses, Silver Reclaims $50 With Shutdown End In Sight: What's Moving Markets Tuesday? - Benzinga
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Kessler Topaz Meltzer & Check, LLPClass Action - GlobeNewswire
Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately - PR Newswire
Dexcom Insider Bought Shares Worth $1,001,702, According to a Recent SEC Filing - MarketScreener
Dexcom: President Leach buys $1M+ in shares - Investing.com India
Dexcom: President Leach buys $1M+ in shares By Investing.com - Investing.com Canada
Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. - GlobeNewswire
DexCom (DXCM) Analyst Rating Update: Morgan Stanley Lowers Price - GuruFocus
Shareholders who lost money in shares of DexCom, Inc. - GlobeNewswire
Lowey Dannenberg Notifies DexCom, Inc. (“DexCom” or the - GlobeNewswire
DexCom, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before December 26, 2025 to Discuss Your RightsDXCM - Morningstar
Is DexCom Inc. (DC4) stock cheap by valuation metrics2025 Fundamental Recap & Accurate Entry/Exit Alerts - newser.com
DXCM STOCK NOTICE: DexCom, Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by December 26 Deadline - Newsfile
Building trade automation scripts for DexCom Inc.2025 Trading Volume Trends & Real-Time Volume Surge Alerts - newser.com
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - Morningstar
Wall Street Zen Upgrades DexCom (NASDAQ:DXCM) to Strong-Buy - Defense World
DXCM CLASS REMINDER: DexCom, Inc. Investors with Losses May - GlobeNewswire
DexCom (NASDAQ:DXCM) Hits New 12-Month Low After Analyst Downgrade - Defense World
Lost Money on DexCom, Inc. (DXCM)? Contact Levi & Korsinsky Before December 26, 2025 to Join Class Action - ACCESS Newswire
Why TAL Education, Shake Shack And DexCom Just Appeared On Value Investors' Radars - Benzinga
DexCom Inc. stock outlook for YEAR2025 Volume Leaders & Low Drawdown Momentum Trade Ideas - newser.com
DexCom (DXCM) Analyst Ratings: Argus Research Lowers Price Targe - GuruFocus
DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 26, 2025DXCM - NewMediaWire
Levi & Korsinsky Urges DexCom, Inc. (DXCM) Shareholders to Act Before Lead Plaintiff Deadline December 26, 2025 - ACCESS Newswire
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
0.62%
자본화:
|
볼륨(24시간):